News
The experimental mRNA vaccine developed at the University of Florida has shown the ability to supercharge the immune system ...
A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...
2d
MedPage Today on MSNKennedy's mRNA Moves Anger MAHA Allies; Winning Back NIH Grants; Start-Up Games HSAsMary Talley Bowden, MD, founder of Americans for Health Freedom, an advocacy group that has lobbied against mRNA shots, ...
19h
News-Medical.Net on MSNNew model predicts mRNA protein production, accelerating drug and vaccine discoveryA new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...
Researchers at the University of Florida have developed a new mRNA-based vaccine that, when combined with checkpoint ...
What if mRNA vaccines could be made more powerful and less irritating? Scientists at the University of Pennsylvania have ...
2d
Zacks Investment Research on MSNModerna (MRNA) Stock Slides as Market Rises: Facts to Know Before You TradeModerna (MRNA) closed at $34.01 in the latest trading session, marking a -1.9% move from the prior day. This change lagged the S&P 500's daily gain of 0.07%. Meanwhile, the Dow lost 0.7%, and the ...
In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...
Indeed, mRNA vaccines designed to treat cancer (among other diseases) “are quite realistic,” says Anna Blakney, an RNA researcher at the University of British Columbia.
Researchers used a capsule engineered to prevent stomach acids from degrading liquid mRNA therapy to treat inflammatory bowel ...
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 percent higher in participants who were aged 65 years or older. Previous trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results